AACR 2011 annual meeting in Orlando

Sally Church, PhD will be attending the American Association for Cancer Research (AACR) 2011 annual meeting in Orlando that starts this Saturday.

This meeting offers insight into the next generation of PI3K, Akt and mTOR inhibitors, and which compounds have promise for future clinical development.

This is Sally’s favorite meeting of the year as it gives a relaxed opportunity to meet with leading scientists in preclinical drug development and translational medicine.

There will be over 5000 posters, so we hope Sally goes with comfortable shoes for all the walking!  You can read updates from the meeting on Pharma Strategy Blog.

, , , , , , , , , , , , , , , , , , , , , ,

error: Content is protected !!